What is the ticker symbol for Seaport Therapeutics?

Seaport Therapeutics trades under the ticker SPTX on NASDAQ.

What sector does Seaport Therapeutics operate in?

Seaport Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SPTX in a portfolio?

PortView shows SPTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Seaport Therapeutics (SPTX) Stock Analysis

NASDAQHealthcareBiotechnology

$24.38+3.27%

1-year price historyRange $15.25 – $27.84

52-week range$24.38

$14.85$28.38

What Seaport Therapeutics does

Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.

Key metrics

Market cap

$1.31B

P/E (TTM)

-13.70

EPS (TTM)

$-1.78

Beta

1.13

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$21.98

200-day avg

$19.97

52-week high

$28.38

52-week low

$14.85

CEO

Daphne Zohar

ETFs linked to SPTX

Broad-market and Healthcare sector ETFs an investor holding Seaport Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SPTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SPTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Seaport Therapeutics?: Seaport Therapeutics trades under the ticker SPTX on NASDAQ.
Which exchange is SPTX listed on?: SPTX is listed on NASDAQ.
What sector does Seaport Therapeutics operate in?: Seaport Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SPTX in a portfolio?: PortView shows SPTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.